PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-03-19

Date Title Company
19-Mar-2020 Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences Danaher Corporation
19-Mar-2020 Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs Mylan N.V.
19-Mar-2020 Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs Mylan N.V.
19-Mar-2020 RB Brings Digital R&D Advances to Popular Consumer Products Through Collaboration with Eagle Genomics RB
19-Mar-2020 Biotech Companies Concentrate on Vaccine Formulation and Distribution FinancialBuzz.com
19-Mar-2020 Biotech Companies Concentrate on Vaccine Formulation and Distribution FinancialBuzz.com
19-Mar-2020 Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs Albumedix Ltd
19-Mar-2020 Medios AG acquires Kölsche Blister GmbH and raises debt capital to finance growth and possible future acquisitions Medios AG
19-Mar-2020 Medios AG acquires Kölsche Blister GmbH and raises debt capital Medios AG
19-Mar-2020 ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company ADC Therapeutics SA
19-Mar-2020 Paragon Genomics Introduces CleanPlex® SARS-CoV-2 NGS Panel for Research and Surveillance of COVID-19 Coronavirus Paragon Genomics, Inc.
19-Mar-2020 Neurofibromatosis Therapeutics Analysis, Clinical Trials and Developments Pharma Proff
19-Mar-2020 EVOTEC SE TO REPORT FISCAL YEAR 2019 RESULTS ON 26 MARCH 2020 Evotec SE
19-Mar-2020 Stabilitech's COVID-19 Vaccine Intended to Be Delivered in a Disruptive Thermally Stable Oral Capsule Stabilitech Biopharma Ltd
19-Mar-2020 Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update Heidelberg Pharma AG
19-Mar-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its Full Year 2019 Results on March 26, 2020 Vivoryon Therapeutics AG
19-Mar-2020 Zur Rose Group maintains growth momentum Zur Rose Group AG